Skip to main content
Erschienen in: Osteoporosis International 7/2008

01.07.2008 | Original Article

Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis

verfasst von: A. M. Delany, D. J. McMahon, J. S. Powell, D. A. Greenberg, E. S. Kurland

Erschienen in: Osteoporosis International | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Summary

Animal models suggest a role for osteonectin/SPARC in determination of bone mass. We found haplotypes consisting of three single nucleotide polymorphisms (SNPs) in the 3′ untranslated region (UTR) of the osteonectin gene are associated with bone density in Caucasian men with idiopathic osteoporosis.

Introduction

Osteonectin is a matricellular protein regulating matrix assembly, osteoblast differentiation, and survival. Animal studies indicate that osteonectin is essential for normal bone mass. The 3′ UTR is a regulatory region controlling mRNA stability, trafficking, and translation, and we determined whether osteonectin 3′ UTR haplotypes could be associated with bone mass and/or idiopathic osteoporosis.

Methods

Single strand conformation polymorphism and allele-specific PCR analysis were used to assess alleles at osteonectin cDNA bases 1046, 1599, and 1970, using genomic DNA from middle-aged Caucasian men with idiopathic, low turnover osteoporosis (n = 56) and matched controls (n = 59). Bone density was measured by DXA at spine, hip and radius. Allele and haplotype frequencies were analyzed by Chi square analysis and Fisher’s exact test.

Results

Five common osteonectin 3′ UTR haplotypes were identified. The frequency of one haplotype (1046C-1599C-1970T) was higher in controls compared with patients, and this haplotype was also associated with higher bone densities at multiple sites in patients. In contrast, a second haplotype (1046C-1599G-1970T) was associated with lower bone densities in patients at multiple sites.

Conclusions

Osteonectin regulates skeletal remodeling and bone mass in animals, and haplotypes in the 3′ UTR of this gene are associated with bone density in Caucasian men with idiopathic osteoporosis.
Literatur
1.
Zurück zum Zitat Stewart TL, Ralston SH (2000) Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166:235–245PubMedCrossRef Stewart TL, Ralston SH (2000) Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166:235–245PubMedCrossRef
2.
Zurück zum Zitat Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMedCrossRef Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMedCrossRef
3.
Zurück zum Zitat Kurland ES, Chan FK, Rosen CJ, Bilezikian JP (1998) Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 83:2576–2579PubMedCrossRef Kurland ES, Chan FK, Rosen CJ, Bilezikian JP (1998) Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 83:2576–2579PubMedCrossRef
4.
Zurück zum Zitat Cardon LR, Garner C, Bennett ST, Mackay IJ, Edwards SM, Cornish J, Hegde M, Murray MAF, Reid IR, Cundy T (2000) Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 15:1132–1137PubMedCrossRef Cardon LR, Garner C, Bennett ST, Mackay IJ, Edwards SM, Cornish J, Hegde M, Murray MAF, Reid IR, Cundy T (2000) Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 15:1132–1137PubMedCrossRef
5.
Zurück zum Zitat Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM (2004) Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 89:4949–4953PubMedCrossRef Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM (2004) Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 89:4949–4953PubMedCrossRef
6.
Zurück zum Zitat Evans SF, Davie MWJ (2002) Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture. Calcif Tissue Int 70:9–15PubMedCrossRef Evans SF, Davie MWJ (2002) Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture. Calcif Tissue Int 70:9–15PubMedCrossRef
7.
Zurück zum Zitat Kurland ES, Khosla S, Colvin TL, Heller SL, Powell J, Seltzer B, McMahon D, Bilezikian JP (2003) The relative role of the sex steroids in idiopathic osteoporosis in men. J Bone Miner Res 18(Suppl):SA331 (abstract) Kurland ES, Khosla S, Colvin TL, Heller SL, Powell J, Seltzer B, McMahon D, Bilezikian JP (2003) The relative role of the sex steroids in idiopathic osteoporosis in men. J Bone Miner Res 18(Suppl):SA331 (abstract)
8.
Zurück zum Zitat Giguere Y, Rousseau F (2000) The genetics of osteoporosis: “complexities and difficulties” Clin Genet 57:161–169PubMedCrossRef Giguere Y, Rousseau F (2000) The genetics of osteoporosis: “complexities and difficulties” Clin Genet 57:161–169PubMedCrossRef
9.
Zurück zum Zitat Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049–1054PubMedCrossRef Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049–1054PubMedCrossRef
10.
Zurück zum Zitat Barker TH, Baneyx G, Cardo-Vila m, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase. J Biol Chem 280:36483–36493PubMedCrossRef Barker TH, Baneyx G, Cardo-Vila m, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase. J Biol Chem 280:36483–36493PubMedCrossRef
11.
Zurück zum Zitat Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E (2000) Osteopenia and decreased bone formation in osteonectin-null mice. J Clin Invest 105:915–923PubMedCrossRef Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E (2000) Osteopenia and decreased bone formation in osteonectin-null mice. J Clin Invest 105:915–923PubMedCrossRef
12.
Zurück zum Zitat Kessler C, Delany AM (2007) Increased notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. Endocrinology 148:1666–1674PubMedCrossRef Kessler C, Delany AM (2007) Increased notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. Endocrinology 148:1666–1674PubMedCrossRef
13.
Zurück zum Zitat Fedarko NS, Moerike M, Brenner R, Gehron Robey P, Vetter U (1992) Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 7:921–930PubMedCrossRef Fedarko NS, Moerike M, Brenner R, Gehron Robey P, Vetter U (1992) Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 7:921–930PubMedCrossRef
14.
Zurück zum Zitat Fedarko NS, Gehron Robey P, Vetter UK (1995) Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 10:1122–1129PubMed Fedarko NS, Gehron Robey P, Vetter UK (1995) Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 10:1122–1129PubMed
15.
Zurück zum Zitat Muriel MP, Bonaventure J, Stanescu R, Maroteaux P, Guenet JL, Stanescu V (1991) Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone 12:241–248PubMedCrossRef Muriel MP, Bonaventure J, Stanescu R, Maroteaux P, Guenet JL, Stanescu V (1991) Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone 12:241–248PubMedCrossRef
16.
Zurück zum Zitat Fisher LW, Drum MA, Gehron Robey P, Conn KM, Termine JD (1987) Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI. Calcif Tissue Int 40:260–264PubMedCrossRef Fisher LW, Drum MA, Gehron Robey P, Conn KM, Termine JD (1987) Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI. Calcif Tissue Int 40:260–264PubMedCrossRef
17.
Zurück zum Zitat Kessler C, Delany AM (2006) Osteonectin/SPARC is critical for anabolic response to PTH in the skeleton. J Bone Miner Res 21S1:S134 Kessler C, Delany AM (2006) Osteonectin/SPARC is critical for anabolic response to PTH in the skeleton. J Bone Miner Res 21S1:S134
18.
Zurück zum Zitat Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E (2003) Osteonectin-null mutation compromises osteoblast formation, maturation and survival. Endocrinology 144:2588–2596PubMedCrossRef Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E (2003) Osteonectin-null mutation compromises osteoblast formation, maturation and survival. Endocrinology 144:2588–2596PubMedCrossRef
19.
Zurück zum Zitat Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411–414PubMedCrossRef Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411–414PubMedCrossRef
20.
Zurück zum Zitat Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, Wang A, Arnett FC (2002) Association of novel polymorphisms with expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 46:2900–2999CrossRef Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, Wang A, Arnett FC (2002) Association of novel polymorphisms with expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 46:2900–2999CrossRef
21.
Zurück zum Zitat Lagan AL, Pantelidis P, Renzoni EA, Fonseca C, Beirne P, Taegtmeyer AB, Denton CP, Black CM, Wells AU, duBios RM, Welsh KI (2005) Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatology 44:197–201PubMedCrossRef Lagan AL, Pantelidis P, Renzoni EA, Fonseca C, Beirne P, Taegtmeyer AB, Denton CP, Black CM, Wells AU, duBios RM, Welsh KI (2005) Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatology 44:197–201PubMedCrossRef
22.
Zurück zum Zitat Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformantics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ, pp 365–386 Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformantics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ, pp 365–386
23.
Zurück zum Zitat Evans AL, Brice G, Sotirova V, Mortimer P, Beninon J, Burnand K, Rosbotham J, Chile A, Sarfarazi M (1999) Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64:547–555PubMedCrossRef Evans AL, Brice G, Sotirova V, Mortimer P, Beninon J, Burnand K, Rosbotham J, Chile A, Sarfarazi M (1999) Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64:547–555PubMedCrossRef
24.
Zurück zum Zitat Bassam BJ, Caitano-Annoles G, Gresshoff PM (1991) Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80–83PubMedCrossRef Bassam BJ, Caitano-Annoles G, Gresshoff PM (1991) Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80–83PubMedCrossRef
25.
Zurück zum Zitat Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM (2005) Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20:185–194PubMedCrossRef Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM (2005) Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20:185–194PubMedCrossRef
26.
Zurück zum Zitat Swaroop A, Hogan BL, Franke U (1988) Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression and localization of the gene to chromosome 5q31–33. Genomics 2:37–47PubMedCrossRef Swaroop A, Hogan BL, Franke U (1988) Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression and localization of the gene to chromosome 5q31–33. Genomics 2:37–47PubMedCrossRef
27.
Zurück zum Zitat Villarreal XC, Mann KG, Long GL (1989) Structure of human osteonectin based upon analysis of cDNA and genomic sequences. Biochemistry 28:6483–6491PubMedCrossRef Villarreal XC, Mann KG, Long GL (1989) Structure of human osteonectin based upon analysis of cDNA and genomic sequences. Biochemistry 28:6483–6491PubMedCrossRef
28.
Zurück zum Zitat Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD (1988) Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor. Proc Natl Acad Sci USA 85:2919–2923PubMedCrossRef Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD (1988) Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor. Proc Natl Acad Sci USA 85:2919–2923PubMedCrossRef
29.
Zurück zum Zitat McVey JH, Nomura S, Kelly P, Mason IJ, Hogan BL (1988) Characterization of the mouse SPARC/osteonectin gene. J Biol Chem 263:11111–11116PubMed McVey JH, Nomura S, Kelly P, Mason IJ, Hogan BL (1988) Characterization of the mouse SPARC/osteonectin gene. J Biol Chem 263:11111–11116PubMed
30.
Zurück zum Zitat Liu Y-J, Shen H, Xiao P, Xiong D-H, Li L-H, Recker RR, Deng H-W (2006) Molecular genetic studies of gene identification for osteoporosis. A 2004 update. J Bone Miner Res 21:1511–1535PubMedCrossRef Liu Y-J, Shen H, Xiao P, Xiong D-H, Li L-H, Recker RR, Deng H-W (2006) Molecular genetic studies of gene identification for osteoporosis. A 2004 update. J Bone Miner Res 21:1511–1535PubMedCrossRef
31.
Zurück zum Zitat Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D’Agostino D, Jannausch M (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695–705PubMedCrossRef Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D’Agostino D, Jannausch M (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695–705PubMedCrossRef
32.
Zurück zum Zitat Ibaraki K, Gehron Robey P, Young MF (1993) Partial characterization of a novel “GGA” factor which binds to the osteonectin promoter in bovine bone cells. Gene 130:225–232PubMedCrossRef Ibaraki K, Gehron Robey P, Young MF (1993) Partial characterization of a novel “GGA” factor which binds to the osteonectin promoter in bovine bone cells. Gene 130:225–232PubMedCrossRef
33.
Zurück zum Zitat Hafner M, Zimmermann K, Pottgiesser J, Kreig T, Nischt R (1995) A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. Matrix Biol 14:733–741PubMedCrossRef Hafner M, Zimmermann K, Pottgiesser J, Kreig T, Nischt R (1995) A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. Matrix Biol 14:733–741PubMedCrossRef
34.
Zurück zum Zitat Dominguez P, Ibaraki K, Gehron Robey P, Hefferan TE, Termine JD, Young MF (1991) Expression of the osteonectin gene potentially controlled by multiple cis- and trans-acting factors in cultured bone cells. J Bone Miner Res 6:1127–1136PubMed Dominguez P, Ibaraki K, Gehron Robey P, Hefferan TE, Termine JD, Young MF (1991) Expression of the osteonectin gene potentially controlled by multiple cis- and trans-acting factors in cultured bone cells. J Bone Miner Res 6:1127–1136PubMed
35.
Zurück zum Zitat Nomura S, Hashmi S, McVey JH, Ham J, Parker M, Hogan BLM (1989) Evidence for positive and negative regulatory elements in the 5’-flanking sequence of the mouse SPARC (osteonectin) gene. J Biol Chem 264:12201–12207PubMed Nomura S, Hashmi S, McVey JH, Ham J, Parker M, Hogan BLM (1989) Evidence for positive and negative regulatory elements in the 5’-flanking sequence of the mouse SPARC (osteonectin) gene. J Biol Chem 264:12201–12207PubMed
36.
Zurück zum Zitat Wrana JL, Overall CM, Sodek J (1991) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Eur J Biochem 197:519–528PubMedCrossRef Wrana JL, Overall CM, Sodek J (1991) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Eur J Biochem 197:519–528PubMedCrossRef
37.
Zurück zum Zitat Ng KW, Manji SS, Young MF, Findlay DM (1989) Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts. Mol Endocrinol 3:2079–2085PubMed Ng KW, Manji SS, Young MF, Findlay DM (1989) Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts. Mol Endocrinol 3:2079–2085PubMed
38.
Zurück zum Zitat Delany AM, Canalis E (1998) Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. Am J Physiol 274 (Cell Physiol. 43) C734–C740PubMed Delany AM, Canalis E (1998) Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. Am J Physiol 274 (Cell Physiol. 43) C734–C740PubMed
Metadaten
Titel
Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis
verfasst von
A. M. Delany
D. J. McMahon
J. S. Powell
D. A. Greenberg
E. S. Kurland
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 7/2008
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0523-9

Weitere Artikel der Ausgabe 7/2008

Osteoporosis International 7/2008 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.